Investor Update
Basel 16 October 2009
Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin Application for Approval of Additional Indication of Breast Cancer
Dear Investor,
Please find enclosed a press release by Chugai:
Basel 16 October 2009
Dear Investor,
Please find enclosed a press release by Chugai: